Denmark’s Fraud Squad is ready to go to court in what is being billed as Denmark’s most serious insider trading case ever.
The case involves a former Novo Nordisk investment adviser with responsibility for the U.S. market who is alleged to have traded Novo stock 13 times between 2005-2008 in the days up to stock exchange announcements, according to Jyllands-Posten.
